[6] In 1998, the company invested $8 million for the acquisition of a building intended to house its head office, administrative centre and operating activities, in the west end of Montreal.

While working on the construction of the distribution centre in 1999, Pharmascience Inc. announced a total investment of $50 million to expand and modernize its infrastructure and create 200 new jobs over the next five years.

[11] In 2012, the company obtained its Class A Operational Excellence certification for customer service and also implemented its Next Generation Leaders (NGL) program.

[13] In 2014, Pharmascience Inc. acquired Uman Pharma Inc., a fully integrated company that develops, manufactures and markets generic injectable pharmaceutical products.

[18] Also in 2019, Pharmascience Inc. signed a partnership agreement with Sama AlFayhaa, the largest pharmaceutical company in southern Iraq, in the same year.

[19] Morris Goodman, born in 1931 in Montreal to Ukrainian parents,[20] is a figure of Canadian entrepreneurship and a pioneer of the generic drug industry.

Upon graduation, he began his career at Pharmascience in Business Development, before taking charge of the future of the company, both in Canada and internationally.

After graduating, he began his career at Pharmascience in business development, before taking charge of the company's future, both in Canada and abroad.

Pharmascience Canada provides private label non-prescription drugs to major Canadian grocery and drugstore chains, as well as to distributors.

The division also manufactures different OTC brands: Prospan by Helixia, Lax A Day,[29] Hemovel, Rhinaris and Pediatric Electrolyte for Kids.

Pharmascience International has a direct presence in the following countries: Vietnam, Kingdom of Saudi Arabia (also responsible for United Arab Emirates, Kuwait, Bahrain, Qatar and Oman), South Korea and Ukraine.

[30] In addition to marketing, the division is involved in licensing, partnership, and development of specialty prescription medicines and consumer healthcare products.

It is equipped to meet the tests required by Health Canada for companies legally authorized to produce, sell or distribute cannabis.